jt-001

Small moleculeexperimental

Clinical trial activity

10 trials · 6 clinical orgs · 0 marketing orgs

Phase 1
5
Phase 2
4
Phase 3
5
Phase 4
0

Earliest trial started Nov 8, 2021 (NCT05101135)

Timeline

2020s

  1. Jan 1, 2021

    Earliest Phase 3 Sponsor(trial)

  2. Jan 1, 2022

    Earliest Phase 1 Sponsor(trial)

  3. Jan 1, 2022

    Earliest Phase 2 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Loading structure…

SMILES

O=C(Nc1c2c(cc3c1CCC3)CCC2)NS(=O)(=O)c1cnn2c1OCCC2
Mol. weight
402.48 g/mol
Lipinski Ro5
Pass
Rule of 3
No
Chirality
Achiral Molecule
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06093230Phase 1Jul 28, 2023Government of China, Sponsor GmbH
NCT06093308Phase 1Jul 12, 2023Government of China, Sponsor GmbH
NCT05895812Phase 1May 8, 2023Government of China, Sponsor GmbH
NCT05802810Phase 1Mar 18, 2023Government of China, Sponsor GmbH
NCT05582629Phase 3Oct 21, 2022Government of China, Sponsor GmbH
NCT05355077Phase 1May 2, 2022Government of China, Shanghai Junshi Bioscience Co.,Ltd.
NCT05341609Phase 3Apr 4, 2022Government of China, Jiao Tong University
NCT05279235Phase 3Mar 8, 2022Government of China, Shanghai Junshi Bioscience Co.,Ltd., Sponsor GmbH
NCT05242042Phase 2/Phase 3 (Phase 3)Jan 28, 2022Shanghai JunTop Biosciences Co., LTD, Sponsor GmbH
NCT05101135Phase 3Nov 8, 2021Jeil Pharmaceutical Co., Ltd.
Showing 10 of 10 trials
Page 1 / 1

Organizations

Research & Development (6)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Government of ChinaGovernment8822022
Sponsor GmbHAcademic/Hospital7022022
Shanghai Junshi Bioscience Co.,Ltd.For profit2022022
Jeil Pharmaceutical Co., Ltd.For profit1112021
Jiao Tong UniversityAcademic/Hospital1012022
Shanghai JunTop Biosciences Co., LTDFor profit1112022
6 organizations
Page 1 / 1